secwatch.observer — SEC 8-K summary
======================================

Issuer:     PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT)
CIK:        0000315545
Form:       8-K
Filed at:   2025-06-20T23:59:59+00:00
Accession:  0001641172-25-015695
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Provectus shareholders approve reverse stock split authorization and elect directors at annual meeting
--------------------------------------------------------------------------------

- Stockholders elected all four director nominees: Bailey, Lacey, Pershing, Rodrigues, with >200M votes for each.
- Advisory say-on-pay approved: 195.7M for, 15.1M against, 0.4M abstentions; 138.8M broker non-votes.
- Ratified CBIZ CPAs P.C. as independent auditor for 2025: 337.9M for, 6.2M against, 5.8M abstentions.
- Authorized board to implement reverse stock split at ratio between 1:10 and 1:50; 326.8M for, 18.2M against.
- Authorized reduction in authorized shares by same reverse split ratio; 330.5M for, 16.8M against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/315545/000164117225015695/0001641172-25-015695-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/315545/000164117225015695/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-015695

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer